DreamCIS, Inc. (KOSDAQ:223250)
6,400.00
+140.00 (2.24%)
At close: Jan 28, 2026
DreamCIS Company Description
DreamCIS, Inc. operates as a clinical research organization in South Korea.
It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services.
The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.
DreamCIS, Inc.
| Country | South Korea |
| Founded | 2000 |
| Industry | Commercial Physical and Biological Research |
| Employees | 390 |
Contact Details
Address: Jeokseon-Hyundai Building Seoul, 110-756 South Korea | |
| Phone | 82 2 2010 4500 |
| Website | dreamcis.com |
Stock Details
| Ticker Symbol | 223250 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |